Literature DB >> 20625036

Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2gamma-deficient mice.

Emiko Yoda1, Keiko Hachisu, Yoshitaka Taketomi, Kotomi Yoshida, Masanori Nakamura, Kazutaka Ikeda, Ryo Taguchi, Yoshihito Nakatani, Hiroshi Kuwata, Makoto Murakami, Ichiro Kudo, Shuntaro Hara.   

Abstract

Group VIB Ca(2+)-independent phospholipase A(2)γ (iPLA(2)γ) is a membrane-bound iPLA(2) enzyme with unique features, such as the utilization of distinct translation initiation sites and the presence of mitochondrial and peroxisomal localization signals. Here we investigated the physiological functions of iPLA(2)γ by disrupting its gene in mice. iPLA(2)γ-knockout (KO) mice were born with an expected Mendelian ratio and appeared normal and healthy at the age of one month but began to show growth retardation from the age of two months as well as kyphosis and significant muscle weakness at the age of four months. Electron microscopy revealed swelling and reduced numbers of mitochondria and atrophy of myofilaments in iPLA(2)γ-KO skeletal muscles. Increased lipid peroxidation and the induction of several oxidative stress-related genes were also found in the iPLA(2)γ-KO muscles. These results provide evidence that impairment of iPLA(2)γ causes mitochondrial dysfunction and increased oxidative stress, leading to the loss of skeletal muscle structure and function. We further found that the compositions of cardiolipin and other phospholipid subclasses were altered and that the levels of myoprotective prostanoids were reduced in iPLA(2)γ-KO skeletal muscle. Thus, in addition to maintenance of homeostasis of the mitochondrial membrane, iPLA(2)γ may contribute to modulation of lipid mediator production in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625036      PMCID: PMC2936754          DOI: 10.1194/jlr.M008060

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  71 in total

1.  Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

Authors:  Zhiming Gu; Fredoen Valianpour; Shuliang Chen; Frederic M Vaz; Gertjan A Hakkaart; Ronald J A Wanders; Miriam L Greenberg
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

2.  A novel mechanism for the store-operated calcium influx pathway.

Authors:  Tarik Smani; Sergey I Zakharov; Peter Csutora; Endri Leno; Elena S Trepakova; Victoria M Bolotina
Journal:  Nat Cell Biol       Date:  2004-01-18       Impact factor: 28.824

3.  Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells.

Authors:  Shunzhong Bao; Alan Bohrer; Sasanka Ramanadham; Wu Jin; Sheng Zhang; John Turk
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

Review 4.  Ubiquitin-protein ligases in muscle wasting.

Authors:  Pei Rang Cao; Hannah J Kim; Stewart H Lecker
Journal:  Int J Biochem Cell Biol       Date:  2004-12-14       Impact factor: 5.085

5.  Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population.

Authors:  N P Lang; M S Tonetti; J Suter; J Sorrell; G W Duff; K S Kornman
Journal:  J Periodontal Res       Date:  2000-04       Impact factor: 4.419

6.  A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells.

Authors:  Hiroshi Kuwata; Chikako Fujimoto; Emiko Yoda; Satoko Shimbara; Yoshihito Nakatani; Shuntaro Hara; Makoto Murakami; Ichiro Kudo
Journal:  J Biol Chem       Date:  2007-05-01       Impact factor: 5.157

Review 7.  Alpha-actinin structure and regulation.

Authors:  B Sjöblom; A Salmazo; K Djinović-Carugo
Journal:  Cell Mol Life Sci       Date:  2008-09       Impact factor: 9.261

Review 8.  Antioxidant defense against anthracycline cardiotoxicity by metallothionein.

Authors:  Y James Kang
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

9.  Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.

Authors:  Ashim Malhotra; Irit Edelman-Novemsky; Yang Xu; Heide Plesken; Jinping Ma; Michael Schlame; Mindong Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability.

Authors:  Branka Dabovic; Yan Chen; Cristina Colarossi; Hiroto Obata; Laura Zambuto; Mary Ann Perle; Daniel B Rifkin
Journal:  J Cell Biol       Date:  2002-01-14       Impact factor: 10.539

View more
  19 in total

Review 1.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 2.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

3.  Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation.

Authors:  Yuta Shimanaka; Nozomu Kono; Yoshitaka Taketomi; Makoto Arita; Yoshimichi Okayama; Yuki Tanaka; Yasumasa Nishito; Tatsuki Mochizuki; Hiroyuki Kusuhara; Alexander Adibekian; Benjamin F Cravatt; Makoto Murakami; Hiroyuki Arai
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

Review 4.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

5.  Dynamics of short-term gene expression profiling in liver following thermal injury.

Authors:  Qian Yang; Mehmet A Orman; Francois Berthiaume; Marianthi G Ierapetritou; Ioannis P Androulakis
Journal:  J Surg Res       Date:  2011-10-21       Impact factor: 2.192

6.  Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size.

Authors:  Sung Ho Moon; David J Mancuso; Harold F Sims; Xinping Liu; Annie L Nguyen; Kui Yang; Shaoping Guan; Beverly Gibson Dilthey; Christopher M Jenkins; Carla J Weinheimer; Attila Kovacs; Dana Abendschein; Richard W Gross
Journal:  J Biol Chem       Date:  2016-07-23       Impact factor: 5.157

7.  Genetic Ablation of Calcium-independent Phospholipase A2γ Induces Glomerular Injury in Mice.

Authors:  Hanan Elimam; Joan Papillon; Daniel R Kaufman; Julie Guillemette; Lamine Aoudjit; Richard W Gross; Tomoko Takano; Andrey V Cybulsky
Journal:  J Biol Chem       Date:  2016-05-12       Impact factor: 5.157

Review 8.  Antioxidant Synergy of Mitochondrial Phospholipase PNPLA8/iPLA2γ with Fatty Acid-Conducting SLC25 Gene Family Transporters.

Authors:  Martin Jabůrek; Pavla Průchová; Blanka Holendová; Alexander Galkin; Petr Ježek
Journal:  Antioxidants (Basel)       Date:  2021-04-26

9.  The physiological roles of vesicular GABA transporter during embryonic development: a study using knockout mice.

Authors:  Kenzi Saito; Toshikazu Kakizaki; Ryotaro Hayashi; Hiroshi Nishimaru; Tomonori Furukawa; Yoichi Nakazato; Shigeo Takamori; Satoe Ebihara; Masakazu Uematsu; Masayoshi Mishina; Jun-ichi Miyazaki; Minesuke Yokoyama; Shiro Konishi; Koichi Inoue; Atsuo Fukuda; Manabu Fukumoto; Kenji Nakamura; Kunihiko Obata; Yuchio Yanagawa
Journal:  Mol Brain       Date:  2010-12-30       Impact factor: 4.041

Review 10.  Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes.

Authors:  Ya-Wen Lu; Steven M Claypool
Journal:  Front Genet       Date:  2015-02-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.